Snus use and other correlates of smoking cessation in the Swedish Twin Registry

Psychological Medicine

Volumn 38, Issue 9, 2008, Pages 1299-1308

  Furberg, H ^a   Lichtenstein, P ^b   Pedersen, N L ^b,c   Bulik, C M ^a   Lerman, C ^d   Sullivan, P F ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cessation; Correlates; Smoking; Snus; Sweden

Indexed keywords

ARTICLE; BODY SIZE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; EDUCATIONAL STATUS; FEMALE; HAZARD RATIO; HUMAN; MALE; MARRIAGE; POPULATION BASED CASE CONTROL STUDY; SCREENING TEST; SMOKING CESSATION; SOCIOECONOMICS; TOBACCO DEPENDENCE;

ADULT; BODY MASS INDEX; DISEASES IN TWINS; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SEX DISTRIBUTION; SMOKING CESSATION; SOCIOECONOMIC FACTORS; SWEDEN; TOBACCO USE DISORDER; TOBACCO, SMOKELESS;

EID: 42149182835     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291707002346     Document Type: Article

References (82)

1. Accortt NA, Waterbor JW, Beall C, Howard G (2002). Chronic disease mortality in a cohort of smokeless tobacco users. American Journal of Epidemiology 156, 730-737.
2. Allison PD (1995). Survival Analysis Using the SAS System: A Practical Guide. SAS Institute, Inc.: Cary, NC.
3. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Washington, DC.
4. Asplund K (2003). Smokeless tobacco and cardiovascular disease. Progress in Cardiovascular Diseases 45, 383-394.
5. Asplund K, Nasic S, Janlert U, Stegmayr B (2003). Smokeless tobacco as a possible risk factor for stroke in men: a nested case-control study. Stroke 34, 1754-1759.
6. Audrain JE, Klesges RC, Klesges LM (1995). Relationship between obesity and the metabolic effects of smoking in women. Health Psychology 14, 116-123.
7. Bolinder G, Alfredsson L, Englund A, de Faire U (1994). Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. American Journal of Public Health 84, 399-404.
8. Bonferroni CE (1936). Statistical theory of classification and calculation of probabilities [in Italian]. Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commerciali di Firenze 8, 3-62.
9. Breslau N, Johnson EO (2000). Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health 90, 1122-1127.
10. Breslau N, Johnson EO, Hiripi E, Kessler R (2001). Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Archives of General Psychiatry 58, 810-816.
11. Broms U, Silventoinen K, Lahelma E, Koskenvuo M, Kaprio J (2004). Smoking cessation by socioeconomic status and marital status: the contribution of smoking behavior and family background. Nicotine and Tobacco Research 6, 447-455.
12. Cox DR, Oakes D (1984). Analysis of Survival Data. Chapman & Hall: London.
13. Curvall M, Romert L, Norlen E, Enzell CR (1987). Mutagen levels in urine from snuff users, cigarette smokers and non tobacco users - a comparison. Mutation Research 188, 105-110.
14. Eliasson M, Asplund K, Nasic S, Rodu B (2004). Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. Journal of Internal Medicine 256, 101-110.
15. Evans DM, Martin NG (2000). The validity of twin studies. GeneScreen 1, 77-79.
16. Fagerstrom KO, Schildt EB (2003). Should the European Union lift the ban on snus? Evidence from the Swedish experience. Addiction 98, 1191-1195.
17. Fagerstrom KO, Schneider NG (1989). Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine 12, 159-182.
18. Fernandez E, Garcia M, Schiaffino A, Borras JM, Nebot M, Segura A (2001). Smoking initiation and cessation by gender and educational level in Catalonia, Spain. Preventive Medicine 32, 218-223.
19. Foulds J, Kozlowski L (2007). Snus - what should the public-health response be? Lancet 369, 1976-1978.
20. Foulds J, Ramstrom L, Burke M, Fagerstrom K (2003). Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control 12, 349-359.
21. Foulds J, Steinberg MB, Williams JM, Ziedonis DM (2006). Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug and Alcohol Review 25, 59-71.
22. Furberg AH, Bulik C, Lichtenstein P, Pedersen N, Sullivan PF (2006). Patterns and prevalence of tobacco use in the Swedish Twin Registry. Addiction 101, 1509-1515.
23. Furberg H, Bulik C, Lerman C, Lichtenstein P, Pedersen N, Sullivan P (2005). Is Swedish snus associated with smoking initiation or smoking cessation? Tobacco Control 14, 422-424.
24. Gartner CE, Hall WD, Chapman S, Freeman B (2007). Should the health community promote smokeless tobacco (snus) as a harm reduction measure? Public Library of Science Medicine 4, e185.
25. Gilljam H, Galanti MR (2003). Role of snus (oral moist snuff ) in smoking cessation and smoking reduction in Sweden. Addiction 98, 1183-1189.
26. Ginzel KH, Maritz GS, Marks DF, Neuberger M, Pauly JR, Polito JR, Schulte-Hermann R, Slotkin TA (2007). Critical review: nicotine for the fetus, the infant and the adolescent? Journal of Health Psychology 12, 215-224.
27. Gray N (2005). Mixed feelings on snus. Lancet 366, 966-967.
28. Haglund B, Eliasson M, Stenbeck M, Rosen M (2007). Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scandinavian Journal of Public Health 6, 1-5.
29. Harrell Jr. FE, Lee KL, Mark DB (1996). Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine 15, 361-387.
30. Harrell Jr. FE, Lee KL, Matchar DB, Reichert TA (1985). Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treatment Reports 69, 1071-1077.
31. Hastie T, Tibshiranti R, Friedman J (2001). The Elements of Statistical Learning: Data Mining, Inference and Prediction. Springer: New York.
32. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991). The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction 86, 1119-1127.
33. Hergens MP, Ahlbom A, Andersson T, Pershagen G (2005). Swedish moist snuff and myocardial infarction among men. Epidemiology 16, 12-16.
34. Holm H, Jarvis MJ, Russell MA, Feyerabend C (1992). Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology 108, 507-511.
35. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO (1992). Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? British Medical Journal 305, 1252-1256.
36. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K (1999). Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. Journal of the American College of Cardiology 34, 1784-1790.
37. Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM (2004). Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine and Tobacco Research 6 (Suppl. 3), S363-S369.
38. Janzon E, Engstrom G, Lindstrom M, Berglund G, Hedblad B, Janzon L (2005). Who are the 'quitters'? A cross-sectional study of circumstances associated with women giving up smoking. Scandinavian Journal of Public Health 33, 175-182.
39. Johansson SE, Sundquist K, Qvist J, Sundquist J (2005). Smokeless tobacco and coronary heart disease: a 12-year follow-up study. European Journal of Cardiovascular Prevention and Rehabilitation 12, 387-392.
40. Kaprio J, Koskenvuo M (1988). A prospective study of psychological and socioeconomic characteristics, health behavior and morbidity in cigarette smokers prior to quitting compared to persistent smokers and non-smokers. Journal of Clinical Epidemiology 41, 139-150.
41. Lagergren J, Bergstrom R, Lindgren A, Nyren O (2000). The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. International Journal of Cancer 85, 340-346.
42. Lambe M (2004). Tobacco control, ethics and Swedish snus. Acta Oncologica 43, 3-4.
43. Lambe M (2007). Swedish snus for tobacco harm reduction. Lancet 370, 1206.
44. Lee PN (2007). Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. International Journal of Epidemiology 36, 789-804.
45. Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino GA, Hyland A, Sweanor D, Warner KE, Compton C (2006). The potential impact of a low-nitrosamine smokeless tobacco product on cigarette smoking in the United States: estimates of a panel of experts. Addictive Behaviors 31, 1190-1200.
46. Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biorklund A, Rutqvist LE (1998). Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 82, 1367-1375.
47. Li MD, Kane JK, Konu O (2003). Nicotine, body weight and potential implications in the treatment of obesity. Current Topics in Medical Chemistry 3, 899-919.
48. Liang KY, Zeger SL (1986). Longitudinal data analysis using general linear models. Biometrika 73, 13-22.
49. Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL (2002). The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. Journal of Internal Medicine 252, 184-205.
50. Lichtenstein P, Sullivan PF, Cnattingius S, Gatz M, Johansson S, Carlstrom E, Bjork C, Svartengren M, Wolk A, Klareskog L, de Faire U, Schalling M, Palmgren J, Pedersen NL (2006). The Swedish Twin Registry in the third millennium: an update. Twin Research and Human Genetics 9, 875-882.
51. Lindstrom M, Isacsson SO (2002). Smoking cessation among daily smokers, aged 45-69 years: a longitudinal study in Malmo, Sweden. Addiction 97, 205-215.
52. Lunell E, Lunell M (2005). Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study. Nicotine and Tobacco Research 7, 397-403.
53. Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, Nyren O (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 369, 2015-2020.
54. McKee M, Gilmore A (2007). Swedish snus for tobacco harm reduction. Lancet 370, 1206.
55. Norberg M, Stenlund H, Lindahl B, Boman K, Weinehall L (2006). Contribution of Swedish moist snuff to the metabolic syndrome: a wolf in sheep's clothing? Scandinavian Journal of Public Health 34, 576-583.
56. Novak M, Ahlgren C, Hammarstrom A (2006). A life-course approach in explaining social inequity in obesity among young adult men and women. International Journal of Obesity (London) 30, 191-200.
57. Osler M, Prescott E, Godtfredsen N, Hein HO, Schnohr P (1999). Gender and determinants of smoking cessation: a longitudinal study. Preventive Medicine 29, 57-62.
58. Osterdahl BG, Jansson C, Paccou A (2004). Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. Journal of Agricultural and Food Chemistry 52, 5085-5088.
59. Pedersen NL, Lichtenstein P, Svedberg P (2002). The Swedish Twin Registry in the third millennium. Twin Research 5, 427-432.
60. Perrin EM, Flower KB, Ammerman AS (2005). Pediatricians' own weight: self-perception, misclassification, and ease of counseling. Obesity Research 13, 326-332.
61. Persson PG, Carlsson S, Svanstrom L, Ostenson CG, Efendic S, Grill V (2000). Cigarette smoking, oral moist snuff use and glucose intolerance. Journal of Internal Medicine 248, 103-110.
62. Radzius A, Gallo JJ, Epstein DH, Gorelick DA, Cadet JL, Uhl GE, Moolchan ET (2003). A factor analysis of the Fagerstrom Test for Nicotine Dependence (FTND). Nicotine Tobacco Research 5, 255-260.
63. Ramstrom L (2000). Snuff - an alternative nicotine delivery system. In Nicotine and Public Health (ed. R. Ferrence), pp. 159-178. American Public Health Association: Washington, DC.
64. Ramstrom L (2003a). Patterns of use: a gate leading to smoking or a way out? Nicotine and Tobacco Research 5, 268.
65. Ramstrom L (2003b). Snus: part of the problem or part of the solution? Addiction 98, 1198-1199; discussion 1204-1207.
66. Ramstrom LM, Foulds J (2006). Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control 15, 210-214.
67. Rodu B, Jansson C (2004). Smokeless tobacco and oral cancer: a review of the risks and determinants. Critical Reviews in Oral Biology and Medicine 15, 252-263.
68. Rodu B, Stegmayr B, Nasic S, Asplund K (2002). Impact of smokeless tobacco use on smoking in northern Sweden. Journal of Internal Medicine 252, 398-404.
69. Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K (2003). Evolving patterns of tobacco use in northern Sweden. Journal of Internal Medicine 253, 660-665.
70. Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K (2004). The influence of smoking and smokeless tobacco use on weight amongst men. Journal of Internal Medicine 255, 102-107.
71. Rothman KJ, Greenland S (1998). Modern Epidemiology. Lippincott-Raven: Philadelphia.
72. SAS Institute (2004). SAS/STAT Software: Version 9. SAS Institute, Inc.: Cary, NC.
73. Savitz DA, Meyer RE, Tanzer JM, Mirvish SS, Lewin F (2006). Public health implications of smokeless tobacco use as a harm reduction strategy. American Journal of Public Health 96, 1934-1939.
74. Schildt EB, Eriksson M, Hardell L, Magnuson A (1998). Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. International Journal of Cancer 77, 341-346.
75. Schnoll RA, Lerman C (2006). Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opinion in Emerging Drugs 11, 429-444.
76. Shtatland ES, Cain E, Barton MB (2001). The perils of stepwise logistic regression and how to escape them using information criteria and the output delivery system. In Proceedings of the 26th Annual SAS Users Group International Conference, Long Beach, CA, 22-25 April 2001. Paper 222-26. SAS Institute Inc.: Cary, NC.
77. Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2004). Nicotine replacement therapy for smoking cessation. Cochrane Database System Review, CD000146.
78. Statistics Sweden (1983). Socioekonomisk indelning (SEI). Meddelande i samordningsfragor 1982: 4 (Swedish Socio-economic Classification). Statistics Sweden: Stockholm.
79. Stegmayr B, Eliasson M, Rodu B (2005). The decline of smoking in northern Sweden. Scandinavian Journal of Public Health 33, 321-324; discussion 243.
80. van Loon AJ, Tijhuis M, Surtees PG, Ormel J (2005). Determinants of smoking status: cross-sectional data on smoking initiation and cessation. European Journal of Public Health 15, 256-261.
81. WHO (1998). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation on obesity. World Health Organization: Geneva.
82. Ye W, Ekstrom AM, Hansson LE, Bergstrom R, Nyren O (1999). Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. International Journal of Cancer 83, 223-229.